[Helicobacter pylori and gastroduodenal pathology in patient with chronic renal insufficiency undergoing dialysis].
D000740:Anemia / Q000209:etiology / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D015897:Comorbidity; D004198:Disease Susceptibility; D004359:Drug Therapy, Combination; D004378:Duodenal Diseases / Q000150:complications* / Q000453:epidemiology / Q000382:microbiology; D004381:Duodenal Ulcer / Q000150:complications / Q000453:epidemiology / Q000382:microbiology; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005755:Gastrins / Q000378:metabolism; D016481:Helicobacter Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000503:physiopathology; D016480:Helicobacter pylori; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D008286:Malabsorption Syndromes / Q000209:etiology; D015995:Prevalence; D054328:Proton Pump Inhibitors; D006435:Renal Dialysis / Q000009:adverse effects; D013272:Stomach Diseases / Q000150:complications* / Q000453:epidemiology / Q000382:microbiology; D013276:Stomach Ulcer / Q000150:complications / Q000453:epidemiology / Q000382:microbiology; D014508:Urea / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D004791:Enzyme Inhibitors; D005755:Gastrins; D054328:Proton Pump Inhibitors; D014508:Urea
Helicobacter pylori y patología gastroduodenal en pacientes con insuficiencia renal crónica en diálisis.